Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical LDE225 cream versus vehicle for basal cell carcinoma in adults with nevoid basal cell carcinoma syndrome
2010-019856-30Phase 3Terminated
- Sponsor
- Novartis
- Start
- Jun 2010
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in basal cell carcinoma (BCC) and Basal cell nevus syndrome (BCNS) comparing LDE225 topical cream with Vehicle cream (2 arms). Started Jun 2010; status: terminated.
02
Drugs
sonidegib
03
Conditions
basal cell carcinoma (BCC)Basal cell nevus syndrome (BCNS)
Beyond the preview
Go deeper on 2010-019856-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019856-30.